Skip to main content
Come to our first #HealthLiteracy poster of #ACR25!
#0190
Cluster analysis >900 people with IA
Lowest health literacy

Mrinalini Dey DrMiniDey

11 months 1 week ago
Come to our first #HealthLiteracy poster of #ACR25! #0190 Cluster analysis >900 people with IA Lowest health literacy cluster assoc w: 4× ⬆️anxiety/depression 2× ⬆️disease activity, vs highest HL Higher HL assoc w older age & ⬆️comorbidities but fewer mental health Sx @RheumNow https://t.co/iIRXaOl4qZ
How does cMRI change over time in cardiac EGPA?

Cheng et al. retrospectively reviewed:
- 11 EGPA pt with LGE on initia

Brian Jaros, MD Dr_Brian_MD

11 months 1 week ago
How does cMRI change over time in cardiac EGPA? Cheng et al. retrospectively reviewed: - 11 EGPA pt with LGE on initial cMRI Despite treatment: - 10/11 persistent LGE on 2nd cMRI - 4/4 on 3rd - 2/2 on 4th Unclear use as a monitor of tx response @RheumNow #ACR25
#0773 Anti-MDA5 epitope mapping identifies key regions (aa 201-300, 601-700) linked to treatment resistance & poor p

Mrinalini Dey DrMiniDey

11 months 1 week ago
#0773 Anti-MDA5 epitope mapping identifies key regions (aa 201-300, 601-700) linked to treatment resistance & poor prognosis in DM-ILD and even IIPs. Epitope-specific antibodies could refine risk stratification & guide therapy in ILD beyond autoimmune disease. @RheumNow #ACR25 https://t.co/moRffVGZPn
#ACR25 Abstr#0772. Should we be worried of #SLE patients with low uPCR 0.25-0.49? Kidney biopsy in N=28 + poor prognosti

Md Yuzaiful Md Yusof Yuz6Yusof

11 months 1 week ago
#ACR25 Abstr#0772. Should we be worried of #SLE patients with low uPCR 0.25-0.49? Kidney biopsy in N=28 + poor prognostic (Non-White, active serology or active sediment) - 71% had LN (No class IV or Mixed) - 46% actionable LN Cost-effectiveness data needed. #ACRBest @RheumNow https://t.co/Bt3fuA3aJh
Organ Specific Recommendations-ACR guidelines for Management of SLE by Dr Lisa Sammaritano. @RheumNow #ACR2025 https://t

Dr M Nazibur Rahman, MD (Rheumatology) NaziburM

11 months 1 week ago
Organ Specific Recommendations-ACR guidelines for Management of SLE by Dr Lisa Sammaritano. @RheumNow #ACR2025 https://t.co/ilKWG8CQbe
AI-enhanced MRI integrating STIR and T1-weighted MRI with BME data reflecting both inflammatory and structural changes,

Antoni Chan MD (Prof) synovialjoints

11 months 1 week ago
AI-enhanced MRI integrating STIR and T1-weighted MRI with BME data reflecting both inflammatory and structural changes, enabling the AI model to predict clinical diagnoses of axSpA with accuracy of 82%. Successfully identified axSpA patients who did not meet the ASAS criteria for https://t.co/dLlGj0ZFpj
Join us at 5pm CST for Day 1 #ACR25 recap! https://t.co/EwZSiPhysF

Dr. John Cush RheumNow

11 months 1 week ago
Join us at 5pm CST for Day 1 #ACR25 recap! https://t.co/EwZSiPhysF
The pharmacology treatment including biologics, cellular-based therapies, and Bi-specific T-cell Engager (BiTE) in systemic lupus erythematosus (SLE) is a rapidly expanding field of research that provides excitement and optimism to both the patients and the physicians.
Plenary session at #ACR25!

#0772 When should we biopsy in SLE?
In pts with uPCR 0.25-0.49 g/g + LN predictors, 69% alre

Mrinalini Dey DrMiniDey

11 months 1 week ago
Plenary session at #ACR25! #0772 When should we biopsy in SLE? In pts with uPCR 0.25-0.49 g/g + LN predictors, 69% already had LN (many Class III/V). Low C3/C4 were most important factors. 0.5 g/g cutoff may delay diagnosis and treatment. Time to rethink thresholds? @RheumNow
#LLM can be #virtual #tutor for
👇
#OSCE

RCT - better competence &confidence

#AI & #medical #education

AI

Janet Pope Janetbirdope

11 months 1 week ago
#LLM can be #virtual #tutor for 👇 #OSCE RCT - better competence &confidence #AI & #medical #education AI trained to #tutor Also grading OSCE #AI + human @RheumNow @ACRheum #26S17 https://t.co/CzKoxyjpY8
Early, low level proteinuria is a harbinger in SLE. ~50% with elevated UPCR but <0.5 had actionable LN on early bx.

Brian Jaros, MD Dr_Brian_MD

11 months 1 week ago
Early, low level proteinuria is a harbinger in SLE. ~50% with elevated UPCR but <0.5 had actionable LN on early bx. Risk factor = low c3/c4 Urine biomarkers promising #ACRBest #ACR25 @RheumNow https://t.co/WuNPKeqeid
#Pros and #cons of #AI

Need to know both
Need to assess AI #quality and #accuracy

‘Assume AI WILL be used’
JHausm

Janet Pope Janetbirdope

11 months 1 week ago
#Pros and #cons of #AI Need to know both Need to assess AI #quality and #accuracy ‘Assume AI WILL be used’ JHausmann By trainees, patients and medical personnel Train #faculty re #AI #ACR25 @RheumNow @ACRheum #26S17 https://t.co/CvPDQPbueW
What's new in the Pre-RA world?
Slowly unraveling mechanisms and biology associated to transition from CCP+ asymptomati

Aurelie Najm AurelieRheumo

11 months 1 week ago
What's new in the Pre-RA world? Slowly unraveling mechanisms and biology associated to transition from CCP+ asymptomatic pre-RA state to clinical RA Here is my summary of a few abstracts presented at #ACR25 proposing biomarkers beyond the realm of clinical and classical
From Dr. Petri at Plenary - even small amounts of proteinuria are a PROBLEM. Reduction of microalbuminuria by even 10% i

Brian Jaros, MD Dr_Brian_MD

11 months 1 week ago
From Dr. Petri at Plenary - even small amounts of proteinuria are a PROBLEM. Reduction of microalbuminuria by even 10% improves mortality! #ACR25 @RheumNow https://t.co/hjmH26vXIb
#AI for medical use is fast moving

governance is Impt

Protect Privacy
Facilitate trainees to LEARN
Involve #IT, ethici

Janet Pope Janetbirdope

11 months 1 week ago
#AI for medical use is fast moving governance is Impt Protect Privacy Facilitate trainees to LEARN Involve #IT, ethicists, users ‘We will enter a world where all we do medically is recorded’ J Hausmann said #ACR25 @RheumNow @ACRheum #26S17 https://t.co/zWjy4u99Yo
×